➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
McKinsey
Mallinckrodt
Boehringer Ingelheim
McKesson

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Cefadroxil/cefadroxil hemihydrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cefadroxil/cefadroxil hemihydrate and what is the scope of freedom to operate?

Cefadroxil/cefadroxil hemihydrate is the generic ingredient in three branded drugs marketed by Aurobindo Pharma, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Warner Chilcott, Bristol, Ani Pharms Inc, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

Seventeen suppliers are listed for this compound.

Summary for cefadroxil/cefadroxil hemihydrate
Pharmacology for cefadroxil/cefadroxil hemihydrate

US Patents and Regulatory Information for cefadroxil/cefadroxil hemihydrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 065115-001 Mar 26, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Cspc Ouyi CEFADROXIL cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 205072-001 Jul 28, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms CEFADROXIL cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 062766-001 Mar 3, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Apothecon CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 062334-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lupin CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 065396-001 Feb 21, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 065396-002 Feb 21, 2008 AB RX No Yes   Start Trial   Start Trial   Start Trial
Hikma Pharms CEFADROXIL cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 091036-002 Nov 28, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Merck
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.